STERIS said the sale of its Dental business segment to HuFriedy Group Holding LLC closed on May 31, 2024. HuFriedy Group Holding LLC is an affiliate of Peak Rock Capital LLC.

8-KRegulation FD DisclosureFiled May 31, 2024Period of report May 31, 2024Summary published (UTC) Oct 30, 2026

Key points

AI summary

STERIS said the sale of its Dental business segment to HuFriedy Group Holding LLC closed on May 31, 2024. HuFriedy Group Holding LLC is an affiliate of Peak Rock Capital LLC.
The company said the sale price for the Dental business segment is $787.5 million, subject to customary adjustments. The deal was first reported in a Current Report on Form 8-K dated April 11, 2024.
The company said the Dental business would pay up to an additional $12.5 million in contingent payment if it reaches certain revenue targets in fiscal 2025.
The company said it plans to use the proceeds from the transaction primarily to repay debt. It also cited the possibility that it may not realize the expected benefits of the transaction, including the earnout payment, as a risk factor.

Summary

AI-written

Analysis scope · Filing bodyWe analyzed the filing body and confirmed exhibits. This is not a review of other exhibits, investor presentations or the full earnings call.

Dental Divestiture Deal Closes

STERIS said the sale of its Dental business segment to HuFriedy Group Holding LLC closed on May 31, 2024. HuFriedy Group Holding LLC is an affiliate of Peak Rock Capital LLC.

Source · Based on the filing body and exhibits

Base Sale Price of $787.5 million

The company said the sale price for the Dental business segment is $787.5 million, subject to customary adjustments. The deal was first reported in a Current Report on Form 8-K dated April 11, 2024.

Source · Based on the filing body and exhibits

Up to $12.5 million in Additional Contingent Payments

The company said the Dental business would pay up to an additional $12.5 million in contingent payment if it reaches certain revenue targets in fiscal 2025.

Source · Based on the filing body and exhibits

Plans for Use of Sale Proceeds

The company said it plans to use the proceeds from the transaction primarily to repay debt. It also cited the possibility that it may not realize the expected benefits of the transaction, including the earnout payment, as a risk factor.

Source · Based on the filing body and exhibits

AI summarized the filing and translated the summary into English; it may differ from the original. For reference only, not investment advice. AI translated the published Korean report into English. Figures are copied as filed, not recalculated.

Original filing

The filing as submitted to SEC EDGAR. You can check the figures and statements of this summary against it.

View the original filing on SEC EDGAR ↗

Unauthorized scraping, data storage and database creation prohibited

Without prior written consent, you must not crawl or scrape data compiled and organized by Chickstock or its analysis and summaries, or collect them repeatedly or in bulk for storage, ingestion or database creation. Repurposing, redistribution, sale and use to build other services are also prohibited.

Unauthorized use may result in access restrictions, demands to stop infringement and delete copies, and claims for damages. Violations of applicable law may also give rise to criminal liability.

Uses permitted by law, the Terms of Service or a separate agreement remain subject to their respective scope. Rights in individual source materials, including original filings, remain with their respective rights holders.